INTRODUCTION
Cell motility, such as smooth muscle contraction and cell migration, is controlled by the reversible phosphorylation of the regulatory light chain of myosin II and other cytoskeletal proteins. Mounting evidence suggests that in smooth muscle cells and other types of cells in vertebrates, myosin phosphatase (MP) plays an important role in controlling the phosphorylation of myosin II as well as other cytoskeletal proteins, including ezrin, moesin, and radixin. 1 MP is a holoenzyme consisting of a catalytic subunit of a type-1 Ser/Thr phosphatase (PP1C) delta isoform, a myosin phosphatase targeting subunit 1 (MYPT1), and an accessory subunit M21. In this ternary complex, MYPT1 is responsible for regulating the phosphatase activity. 1 A recent X-ray crystallographic study revealed an allosteric interaction between PP1C and the N-terminal ankyrin repeat domain of MYPT1 that confers the substrate specificity of the enzyme. 2 MP activity is suppressed when Thr 696 or Thr 853 of MYPT1 is phosphorylated by various kinases, such as ROCK, ZIPK, ILK, and PAK. 1, 3 However, it is still unclear how the phosphorylation of MYPT1 inhibits MP activity.
The amino acid sequence around Thr 696 of MYPT1 is highly conserved among MYPT1 family members including MYPT2 and MBS85. Therefore, structural insights into the inhibitory domain of MYPT1 are expected to provide new clues to fully elucidate the mechanism that controls phosphatase activity via the phosphorylation of MYPT1 or other family members involved in kinase-phosphatase crosstalk in cytoskeletal regulation.
Here, we prepared a bacterial recombinant fragment of MYPT1 corresponding to residues 658 to 714, including the phosphorylation site Thr
696
, and determined its three-dimensional structure through the use of computer-assisted distance geometry and a simulated annealing protocol combined with stable-isotope-aided multi-dimensional NMR techniques.
MATERIALS AND METHODS

Molecular cloning and NMR sample preparation
Protein preparation was performed using a previously reported method. 4 Briefly, the cDNA fragment encoding the 57-residue peptide corresponding to residues 658 to 714 of human MYPT1 was cloned into a modified pET30 vector that produces His x6 fusion protein with a PreScission protease recognition site. To assign the resonances of the side chains, C(CO)NH, H(CCO)NH, 15 N-edited TOCSY, and HCCH-TOCSY spectra were recorded. 7, 8 To obtain distance information, we measured Homonuclear 2D-NOESY, 13 C-edited NOESY, and HCCH-TOCSY were obtained with the sample dissolved in D 2 O. All NOE experiments were acquired using a 150 ms mixing time. The NMR data were processed and displayed by NMRPipe. 9 The processed NMR spectra were displayed and analyzed by Sparky. 10 
Structural calculation
A total of 527 independent unambiguous NOE peaks were selected and used as inputs in the calculation of the structure together with 86 TALOS dihedral angle restraints. 11 Additionally, 62 hydrogen bond restraints based on the secondary structure were used in the calculation. The calculation was executed using the simulated annealing protocol sa.inp in XPLOR-NIH version 2.050. 12 The 20 lowest energy structures were selected from the final calculations for 100 structures. The 20 structures had no distance or angle violations. The quality of the structures was analyzed by Procheck-NMR. 13 The structures were also displayed and analyzed by MOLMOL. 14 
RESULTS AND DISCUSSION
Previous reports have shown that the thiophosphorylated MYPT1 C-terminal fragment and the MBS85 fragment including the inhibitory phosphorylation site inhibit isolated PP1C activity. 4, 5 Indeed, our preliminary study suggests that when the 57-residue MYPT1 fragment containing Thr 696 (MYPT1(658-714)) is phosphorylated, it inhibits the activity of MP purified from smooth muscle cells as well as the activity of the enzyme associated with cytoskeletons in skinned smooth muscle fibers. 5 The amino acid sequence is shown in Figure 1(A) .
We prepared the NMR-active stable-isotope-labeled peptide of this fragment, MYPT1(658-714), by using an Escherichia coli over-expression system. The uniformly 
17,18
The orientation of the three helices was not defined in this structural study. As shown in Table 1 , few long-range NOE signals were observed and were insufficient to determine the overall structure. One possibility of such an ill-defined structure is that the lack of long-range NOE signals is due to the extended molecular shape. Another possibility is that the two loop regions have a degree of flexibility that prevents the convergence of the solution structure. To address this issue, residual dipolar coupling constants (RDCs) can provide useful information. 19 Thus, we attempted to prepare samples for these NMR experiments. However, this was unsuccessful due to unexpected interactions between the MYPT1 fragment and the co-solute, pf1-phage. Therefore, another approach, { 1 H}- 15 N heteronuclear NOE spectroscopy, was used to obtain information about the dynamics (Figure 3) . 20 The loop regions show relatively small values of the peak intensity ratio (NOE on / NOE off ) compared to the three helical regions, which indicates the existence of higher flexibility in the loop regions. Thus, the overall structure of MYPT1(658-714) is variable due to the flexibility of the inter-helical angle.
The phosphorylation site Thr 696 is located at the C-terminal end of helix B.
The structural plasticity of the loop region connecting helix B and C is possibly required for recognition by kinases, such as ROCK, ZIPK, ILK, and PAK. The helical structure of the MYPT1 inhibitory domain is similar to the structure of the autoinhibitory mechanism of calcineurin (CaN). 21 As shown in the crystal structure of the inactive form of CaN without calmodulin, the α-helical autoinhibitory domain directly docks at the active site of CaN. Figure S1
